# clm_E5BB4CC8EC5C

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 6,232,000,000 United States dollar  
valid_from: 2023-12-31  
valid_to: 2024-03-31  
published: 2024-02-14  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_713550ADBC39  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 6,232,000,000 United States dollar", as of 2023-12-31 (until 2024-03-31). Claim clm_E5BB4CC8EC5C, https://asof.is/claim/clm_E5BB4CC8EC5C, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-K FY2023, filed 2024-02-14  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815424000011/0000318154-24-000011-index.htm (primary, SEC EDGAR 10-K FY2023, published 2024-02-14)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 7,656,000,000 United States dollar | valid 2023-09-30 to 2023-12-31 | conf 0.95 | superseded | superseded_by [clm_E5BB4CC8EC5C](/claim/clm_E5BB4CC8EC5C.md) | [clm_C48050D45C2E](/claim/clm_C48050D45C2E.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.